39.84 1.45 (3.78%)

29.95% Fall from 52W High

795.8K XNAS Volume

XNAS 27 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for MoonLake Immunotherapeutics - Ordinary Shares - Class A

The latest disclosure was made by Matthias Bodenstedt in MoonLake Immunotherapeutics - Ordinary Shares - Class A where a trade of 95,763 Class A ordinary shares, par value $0.0001 per share done was reported to US exchanges on Feb. 27, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Matthias Bodenstedt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 95,763 616,666 - 0 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 139,273 139,273 - - Stock Option (Right to Buy)
Jorge Santos da Silva Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 95,763 3,078,577 - 0 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer 20 Jan 2025 3,328 2,508 - - Common shares, par value CHF 0.10 per share, of MoonLake AG
Kristian Reich Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jan 2025 111,949 84,367 - - Class C ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer 20 Jan 2025 111,949 153,930 - - Class A ordinary shares, par value $0.0001 per share
Simon John Sturge Director Sale of securities on an exchange or to another person at price $ 53.72 per share. 04 Oct 2024 171,000 171,980 - 53.7 9,186,120 Class A ordinary shares, par value $0.0001 per share
Andrew Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 7,688 7,688 - - Option to Buy
Simon John Sturge Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 7,688 7,688 - - Option to Buy
Catherine Moukheibir Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 7,688 7,688 - - Option to Buy
Spike Loy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 7,688 7,688 - - Option to Buy
Ramnik Xavier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 7,688 7,688 - - Option to Buy
Santos da Silva Jorge Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 55.00 per share. 27 Feb 2024 56,065 2,987,554 - 55 3,083,575 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 55.00 per share. 27 Feb 2024 31,910 2,925,573 - 55 1,755,050 Class A ordinary shares, par value $0.0001 per share
Jorge Santos da Silva Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 55.00 per share. 27 Feb 2024 62,810 3,043,619 - 55 3,454,550 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 55.00 per share. 27 Feb 2024 29,431 70,071 - 55 1,618,705 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 55.00 per share. 27 Feb 2024 28,090 41,981 - 55 1,544,950 Class A ordinary shares, par value $0.0001 per share
Jorge Santos da Silva Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 55.89 per share. 27 Feb 2024 4,740 2,982,814 - 55.9 264,919 Class A ordinary shares, par value $0.0001 per share
Reich Kristian Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 55.00 per share. 27 Feb 2024 29,491 2,957,483 - 55 1,622,005 Class A ordinary shares, par value $0.0001 per share
Santos da Silva Jorge Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 55.27 per share. 21 Feb 2024 1,125 3,106,429 - 55.3 62,179 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 57.43 per share. 20 Feb 2024 10,000 100,071 - 57.4 574,300 Class A ordinary shares, par value $0.0001 per share
Reich Kristian Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 55.31 per share. 20 Feb 2024 509 2,986,974 - 55.3 28,153 Class A ordinary shares, par value $0.0001 per share
Reich Kristian Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 57.45 per share. 20 Feb 2024 10,000 2,987,483 - 57.5 574,500 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 55.30 per share. 20 Feb 2024 569 99,502 - 55.3 31,466 Class A ordinary shares, par value $0.0001 per share
Santos da Silva Jorge Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 60.15 per share. 15 Feb 2024 20,000 3,127,554 - 60.2 1,203,000 Class A ordinary shares, par value $0.0001 per share
Jorge Santos da Silva Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 57.44 per share. 15 Feb 2024 20,000 3,107,554 - 57.4 1,148,800 Class A ordinary shares, par value $0.0001 per share
Jorge Santos da Silva Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 60.18 per share. 15 Feb 2024 20,000 3,147,554 - 60.2 1,203,600 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 60.15 per share. 14 Feb 2024 10,000 110,071 - 60.2 601,500 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 62.42 per share. 14 Feb 2024 10,000 3,017,483 - 62.4 624,200 Class A ordinary shares, par value $0.0001 per share
Reich Kristian Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 60.17 per share. 14 Feb 2024 10,000 3,007,483 - 60.2 601,700 Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 60.16 per share. 14 Feb 2024 10,000 120,071 - 60.2 601,600 Class A ordinary shares, par value $0.0001 per share
Reich Kristian Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 62.43 per share. 14 Feb 2024 10,000 130,071 - 62.4 624,300 Class A ordinary shares, par value $0.0001 per share
Reich Kristian Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 60.15 per share. 14 Feb 2024 10,000 2,997,483 - 60.2 601,500 Class A ordinary shares, par value $0.0001 per share
Bodenstedt Matthias Chief Financial Officer Sale of securities on an exchange or to another person at price $ 59.22 per share. 19 Dec 2023 94,736 526,167 - 59.2 5,610,266 Class A ordinary shares, par value $0.0001 per share
Matthias Bodenstedt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 58.34 per share. 19 Dec 2023 5,264 520,903 - 58.3 307,102 Class A ordinary shares, par value $0.0001 per share
Catherine Moukheibir Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 11,297 11,297 - - Option to Buy
Andrew Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 11,297 11,297 - - Option to Buy
Spike Loy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 11,297 11,297 - - Option to Buy
Ramnik Xavier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 11,297 11,297 - - Option to Buy
Simon John Sturge Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 11,297 11,297 - - Option to Buy
Kristian Reich Chief Scientific Officer 05 Apr 2023 98,090 98,090 - - Class A ordinary shares, par value $0.0001 per share
Matthias Bodenstedt Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2023 410,796 0 - - Class C ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer 05 Apr 2023 500,006 500,006 - - Class A ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2023 500,006 2,527,477 - - Class C ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2023 98,090 238,297 - - Class C ordinary shares, par value $0.0001 per share
Kristian Reich Chief Scientific Officer 05 Apr 2023 14,864 75,136 - - Common shares, par value CHF 0.10 per share, of MoonLake AG
Kristian Reich Chief Scientific Officer 05 Apr 2023 2,916 7,084 - - Common shares, par value CHF 0.10 per share, of MoonLake AG
Matthias Bodenstedt Chief Financial Officer 05 Apr 2023 4,374 10,626 - - Common shares, par value CHF 0.10 per share, of MoonLake AG
Matthias Bodenstedt Chief Financial Officer 05 Apr 2023 12,212 0 - - Common shares, par value CHF 0.10 per share, of MoonLake AG
Matthias Bodenstedt Chief Financial Officer 05 Apr 2023 410,796 410,796 - - Class A ordinary shares, par value $0.0001 per share
Matthias Bodenstedt Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2023 147,135 357,445 - - Class C ordinary shares, par value $0.0001 per share
Matthias Bodenstedt Chief Financial Officer 05 Apr 2023 147,135 557,931 - - Class A ordinary shares, par value $0.0001 per share
Simon John Sturge Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2022 45,000 45,000 - - Option to Buy
Ramnik Xavier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2022 45,000 45,000 - - Option to Buy
Andrew Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2022 45,000 45,000 - - Option to Buy
Catherine Moukheibir Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2022 45,000 45,000 - - Option to Buy
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures